List of University of Manchester spin-out companies

Please click on logos to link to company website.

A company closely aligned with Manchester’s world-leading graphene group, 2-DTech supplies the highest quality graphene and other 2-D materials internationally. 2-DTech also work closely with industry and researchers to help turn scientific innovation into groundbreaking products

The company is developing a platform diagnostic technology which can be used to detect a range of analytes – from bacteria to small molecules, such as drugs of abuse.

16256 logo development V1

The Arvia water treatment process offers a continuous removal and destruction of toxic and non-biodegradable pollutants. The Arvia? process offers a significant breakthrough in truly cost-effective removal of organic micropollutants.

Arago Technology specialises in developing unique technology that combines Composite Structure and High Voltage Engineering Expertise. Arago also provide consultancy services to enable us to work with our clients to establish how our ground-breaking technology can benefit and revolutionise their businesses.

BiOxyDyn is a company specialising in the development and application of new diagnostic imaging tools and imaging services to improve the understanding of lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma. Bioxydyn are also active in the development of new imaging tools for oncology and neuroscience.

C4X Discovery offers a new platform technology that, for the first time, can rapidly determine highly accurate and biologically-relevant (aqueous) 3D and 4D structures of any small soluble molecule.

Cable-Sense offers Intelligent Infrastructure Management solutions. In the past, ROI models for IIMS have focused on patch fields; Cable-Sense’s extensive functionality delivers significant savings across cabling networks reducing costs in material, energy, capital expenditure and operations.

Clin-e-cal Ltd has been incorporated to make rapid social impact through science, technology and clinical research. Its first product, Rafi-tone, has been designed to help children take their inhaler with a spacer effectively. Using an existing inhaler training aid the app uses novel algorithms which can help the correct technique to be maintained for each dose of the medication helping to ensure treatment is optimised.

Chromition has been founded to supply proprietary ‘Luminspheres’ nanoparticle solutions and to collaborate with application developers to enable the realisation of next-generation technologies. Luminspheres are multicoloured photoluminescent polymer nanoparticles for bioimaging, led lighting and anticounterfeit applications.

Curapel is an award-winning specialist healthcare company committed to the development of innovative and safe therapies for chronic inflammatory skin conditions.

Dmist Research is a specialist supplier of unique technology for the real-time video enhancement of video under adverse conditions – poor weather, poor illumination.

Where there is an operational requirement to ensure high-quality, natural colour, live video regardless of weather-related visibility restrictions, they provide cost-effective solutions.

Dynamic Vision Systems (DVS) Ltd

DVS is developing a novel contact lens for the correction of presbyopia, a condition with 100% prevalence from middle-age onwards. The technology is a wearer-operated, electrically switchable contact lens, using liquid crystal technology to provide electro-active contact lens correction for presbyopia.

ENER-G Combined Power Ltd, a Salford-based global manufacturer of combined heat and power (CHP) systems grew out of one of the University¹s first spin out businesses (Combined Power Systems). Today, ENER-G is Europe¹s leading provider of small scale cogeneration systems – providing business energy solutions to organisations across the world.


Exgence is developing award-winning novel software which automates a key stage in the process of developing business software systems. It converts user requirements, written in plain English, to analysis models that can be used directly as the basis for software development.

F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease.

Gelexir-logo copy

Gelexir Healthcare Ltd develops a Technology using a patented Double Cross linked microgel, designed to be injected into patient’ spine discs to restore normal functioning and to alleviate Chronic Low Back Pain.

Gentronix develops technology for the accurate identification of genotoxic compounds. GreenScreen® products are cell based assays for use in genetic toxicity screening using a simple, rapid and high-throughput protocols.


HiSolar is a social business providing day-lighting, solar powered LED lighting and natural ventilation for the public bathhouses (known as Hammams) of the heritage cities of North Africa.

imorphics provides software tools produced at the leading edge of medical image analysis, and makes them available to clinical research teams throughout the world.

Kesto is a social enterprise which offers a hands-on kit for creative engagement. This ‘workshop in a bag’ provides tabletop tools to record and display people’s ideas, with related workshop methodologies and guidance.

Manchester Imaging Limited is a dental diagnostic software company with a robust platform technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare.

These applications are being designed to identify dental decay and other potential problems earlier, empowering patients to look after their teeth more effectively and saving money for insurance companies and governments by reducing the need for dental restorations and repairs.

Microarray has an innovative technology that enables the manufacture of ultra low cost, high performance sensors, for a wide variety of aqueous sensor applications such as water quality, environmental and medical diagnostics.

microsensor-logo copy

Microsensor Ltd is developing novel point-of-care medical devices for detecting microbial infection. These devices act as an early warning system for infection and can even diagnose which antibiotics will be most effective in treating an emerging infection.

Neuroscience: Applying world-class scientific understanding and innovative technologies to advance the treatment of brain disorders. Cognition: Applying world-class scientific understanding and innovative technologies to advance the treatment of disorders of cognition

Multisensor Systems Ltd is a UK company that provides cost-effective volatile organic compound (VOC) monitoring systems for industrial and environmental applications.

Muscagen Ltd A Cardiff-based spin-out from the Universities of Cardiff and Manchester that aims to develop selective compounds for therapeutic use in treatments covering disorders such as dementia, incontinence and cardiovascular disease. Contact: Prof. Robin Davies at Cardiff University

Mutiny is a unique product within the wide and complex market of network management. It is a product designed by Network Administrators with the user in mind. Its role is to offer an uncomplicated solution to everyday problems and it does this by communicating effectively and unambiguously with the Administrator, in advance of network problems.

Nanoco Technologies Ltd is a world leading nano-technology company which produces fluorescent semiconductor nano-particles quantum dots and quantum dot products.

NeuTec Pharma ltd is a biopharmaceutical company formed in 1997 which specialises in the development of genetically recombinant antibodies, or ?grabs?, for the treatment of life-threatening infections

Photo Therapeutics research, develop and manufacture non-laser light sources with worldwide medical and cosmetic applications.

Opticin Therapeutics is developing novel therapeutics targeting underserved human eye disease, helping those who currently have few or no treatment options.

PentaBee combines ARM and FPGA technologies to create embedded vision systems which combine the task of sensor interfacing, video pipeline and image/data processing with conventional serial processing to create powerful platforms supported by open source tools.

The PETRRA positron camera is a completely novel PET (Positron Emission Tomography) medical imaging system for detection and staging of most types of cancer.

A premier provider of intelligent monitoring and control systems for the process industries


Phagenesis Limited was incorporated in 2007 to facilitate the development of medical device technology for the assessment, treatment and management of dysphagia (swallowing problems) post stroke.

pharmakure-logo copy

Pharmakure is a new drug discovery company focused on Alzheimer’s disease through the discovery of new uses for old drugs, offering great promise for delivering new therapeutic options to patient care. PharmaKure has patented its first drug, PK-048, for the treatment of Alzheimer’s disease.

Plasma Clean specialises in novel technologies to radically improve air quality in commercial, industrial and domestic sectors leading to a healthier environment.

Process Integration Limited (PIL) provides state-of-the-art process improvement technologies for the oil, gas, petrochemical and chemical industries by identifying innovative improvements in operation and design.


Renephra is a medical device development company developing a ground breaking technology address the significant problems of fluid overload and chronic oedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £3billion market worldwide.

The Renephra patented Fluid Removal Device uses micro-needle technology combined with negative pressure therapy to access and remove excess interstitial fluid from the skin

Click here for video

Recently Renephra achieved proof of concept in humans and is now engaged in a major equity fundraising to fund product development and design and clinical validation to regulatory approvals.

Sci-Tron has been founded to commercialise novel nano materials. These include advanced resist materials for the production of integrated circuits and state-of-the-art resins for 3D electron microscopy.

Senexis is a growing, small-molecule drug development company that is committed to revolutionising the treatment and diagnosis of diseases resulting from the inevitable process of ageing.


Spectromics Limited is a medical diagnostic company providing a smarter way to tackle antibiotic resistance, using its rapid point-of-prescription test.

STORM® Skills Training is a social enterprise which provides skills-based self-harm mitigation and suicide postvention training packages to frontline staff in health care, social care, education, and prison services across all sectors.

StrataStem specialise in the derivation of neural cells that allow for cells to be cultured and grown in unprecedented volume and at purity levels that open up applications in drug testing, diagnostics and cellular therapy. The company is looking to establish itself in the field of dementia research and development and in supporting the next generation of effective therapeutics.

TDL design Tunable Laser Gas Sensors for gas measurement applications. Our expertise ranges from new mid-infrared tunable laser sources, near-infrared, and towards the ultra-violet region

TellUs Toolkit is a cloud-based decision support system that supports a wide range of organisations through a tailored package of map-based software tools to support location based business decisions and stakeholder engagement.


Privacy Policy / Terms and Conditions / © Copyright 2015 The University of Manchester Intellectual Property / Created by HTP Digital Marketing Agency

The University of Manchester Intellectual Property ("UMIP") acts solely as agent for the University in relation to any matter relating to intellectual property ("IP") and know how created at the University. This is whether such IP is created by employees, students or others. UMIP does not represent anyone else in such matters. If anyone else requires advice in relation to such IP then they must take their own independent legal advice.